$NVAX Recent Headlines Novavax Inc. up 16% in premarket

New Post Public Reply Private Reply Replies (0) Message Board

Dec 21, 2013 at 10:35 AM

$NVAX Recent Headlines

Novavax Inc. up 16% in premarket 6:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 11:29 a.m. July 25, 2012 - Val Brickates Kennedy
Tuesday’s biggest gainers and decliners 6:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 12:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 10:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 10:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 12:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 5:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 1:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 9:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 2:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 9:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 1:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 9:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch

Piper Jaffray Top Stocks to Buy for 2014 7:44 a.m. Dec. 18, 2013 - 247WallSt.com
Perilous Reversal Watch: Novavax (NVAX) 9:50 a.m. Dec. 17, 2013 - TheStreet.com
Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back 3:07 p.m. Dec. 16, 2013 - benzinga.com
Novavax Share Price Reaches New All-Time High 2:18 p.m. Dec. 16, 2013 - benzinga.com
Novavax jumps, Wedbush sees big upside 11:41 a.m. Dec. 16, 2013 - Seeking Alpha
Five Big Analyst Stock Picks for 2014 7:17 a.m. Dec. 14, 2013 - 247WallSt.com
Can Novavax, Inc. (NVAX) Continue to Rise? - Tale of the Tape 6:24 a.m. Dec. 12, 2013 - Zacks.com
Sell Organovo, Buy Novavax 3:09 a.m. Dec. 11, 2013 - Seeking Alpha
Novavax's CEO Presents at Piper Jaffray HC 2013 Conference (Transcript) 5:30 p.m. Dec. 3, 2013 - Seeking Alpha
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax 12:41 p.m. Nov. 17, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:11 a.m. Nov. 14, 2013 - benzinga.com
Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine 4:26 p.m. Nov. 13, 2013 - benzinga.com
Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript 7:20 p.m. Nov. 7, 2013 - Seeking Alpha
Two Speculative Biotech Stocks 11:00 a.m. Oct. 31, 2013 - RealMoney.com
Buy Novavax On Vaccine Market Growth 2:31 p.m. Oct. 30, 2013 - Seeking Alpha
First Week Of NVAX December 21st Options Trading 10:54 a.m. Oct. 23, 2013 - TheStreet.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
John McCamant Scans Under The Radar For Promising Biotechs 9:11 a.m. Sept. 27, 2013 - Seeking Alpha
NVAX: Insiders Vs. Shorts 2:48 p.m. Sept. 26, 2013 - TheStreet.com

Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Companies Report Corporate Growth and Positive Clinical Data - Research Report on Humana, Molina Healthcare, Novavax, Kindred Healthcare, and Repligen 8:00 a.m. Nov. 27, 2013 - PR Newswire
Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu 5:01 p.m. Nov. 13, 2013 - GlobeNewswire
Novavax Reports Third-Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - GlobeNewswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 12:30 p.m. Nov. 1, 2013 - PR Newswire
Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 3:58 p.m. Oct. 30, 2013 - GlobeNewswire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 2:40 p.m. Oct. 10, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 7:00 a.m. Oct. 9, 2013 - PR Newswire
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate 3:36 p.m. Oct. 7, 2013 - GlobeNewswire
Novavax Completes $100 Million Public Offering of Common Stock 10:29 a.m. Sept. 27, 2013 - GlobeNewswire
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst 7:00 a.m. Sept. 27, 2013 - PR Newswire
Novavax Prices Public Offering of Common Stock 7:07 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 7:00 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Host an Analyst and Investor Update Call With Webcast 5:25 p.m. Sept. 17, 2013 - GlobeNewswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Novavax Highlights Positive Results From Partner's Clinical Trial of Vaccine Using Matrix-M(TM) 8:03 a.m. Sept. 13, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...